Day: March 8, 2022

Generates revenue of $1.9 billion, up 29.7% year-over-year, including organic growth of 9.1% Posts net income of $76.0 million Delivers GAAP EPS of $1.11, Adjusted EPS of $0.94 Initiates share repurchase program Raises guidance for full year GAAP EPS and adjusted EPSNEW YORK, March 08, 2022 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility solutions, today announced financial results for the first quarter of fiscal 2022. Scott Salmirs, ABM’s President and Chief Executive Officer commented, “ABM is off to a great start in 2022 as demonstrated by our solid first quarter results. I am particularly pleased with our organic revenue growth of 9.1%, which reflects improved demand across almost all of our Industry Groups driven by the emerging pandemic recovery and secular trends such as healthy buildings, sustainability...

ALISO VIEJO, Calif., March 08, 2022 (GLOBE NEWSWIRE) — (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today reported financial results for the three months and fiscal year ended December 31, 2021. Recent HighlightsAchieved fourth quarter 2021 revenue of $8.4 million, representing growth of 71% compared to the prior year period and 46% growth over the third quarter of 2021 driven by the:Sale of 45 Light Delivery Devices (LDD™s), expanding the installed base to 206 LDDs as of December 31, 2021; and Sale of 2,959 Light Adjustable Lenses (LAL®s).Achieved fiscal year 2021 revenue of $22.6 million, representing growth of 54% compared to the fiscal year 2020 driven by the:Sale of 114 LDDs; and Sale of 8,328 LALs.“2021 was a very...

Fourth-quarter net product sales from prescriptions increased by 46% to $361,000 versus Q3 Easing of COVID-19 restrictions helped fuel higher sales, increased face-to-face meetings with healthcare professionals SOLANA BEACH, Calif., March 08, 2022 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases, today announced its financial results for the fourth quarter and full year ended December 31, 2021, and recent corporate developments. “We are happy to report that, by several key metrics, we showed encouraging progress over the course of 2021—especially during the fourth quarter—and continuing into 2022 by calling attention to GIMOTI’s value proposition,” said David A. Gonyer, R.Ph., President and CEO of Evoke Pharma. “Our net product...

– Net Sales in the Fourth Quarter of 2021 Increased 15.9% to $117.9 Million, Marking the Sixth Consecutive Quarter of Record Net Sales – – Net Sales in 2021 Increased 15.3% to a Company Record of $444.1 million – – Announces $30 Million Share Repurchase Program – LEHI, Utah, March 08, 2022 (GLOBE NEWSWIRE) — Nature’s Sunshine Products, Inc. (Nasdaq: NATR) (“Nature’s Sunshine” and/or the “Company”), a leading natural health and wellness company of premium-quality herbal and nutritional products, reported financial results for the fourth quarter and full year ended December 31, 2021. Fourth Quarter 2021 Financial Highlights vs. Same Year-Ago QuarterNet sales increased 15.9% to a record $117.9 million compared to $101.7 million. GAAP net income increased 107.6% to $13.8 million, or $0.67 per diluted...

Total Revenue in 2021 Increased to $765.7 millionFourth Quarter Bumble App Revenue Increased 42% to $150.5 millionFourth Quarter Bumble App Paying Users Increased 29% to 1.6 million; Grew 108,000 Quarter Over Quarter AUSTIN, Texas, March 08, 2022 (GLOBE NEWSWIRE) — Bumble Inc. (NASDAQ: BMBL), the parent company of Bumble, Badoo, and Fruitz, today reported financial results for the fourth quarter and full year ended December 31, 2021. “We are pleased to deliver another quarter of strong revenue and adjusted EBITDA growth and are excited to add Fruitz to our family of global, market-leading apps,” said Whitney Wolfe Herd, Founder and CEO of Bumble. “In our first year as a public company, and with our mission at the forefront of everything we do, we successfully executed on our core strategic priorities: driving scale and engagement,...

Strong Finish to the Year Highlighted by Quarterly Revenue Growth, Multi-Year Highs in Quarterly Gross Profit, Operating Income and Adjusted EBITDA Long-Term, Profitable Growth Plan Supported by 15% Increase in Q4 Cloud Revenue, Optimized Cost Structures in Digital and Messaging Company Introduces 2022 Financial Guidance BRIDGEWATER, N.J., March 08, 2022 (GLOBE NEWSWIRE) — Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (NASDAQ: SNCR), a global leader and innovator in cloud, messaging, and digital products and platforms, today reported financial results for its fourth quarter and full year ended December 31, 2021. Fourth Quarter and Recent Operational Highlights:Entered into a definitive agreement for the sale of the Company’s Digital Experience Platform (“DXP”) and Activation Solutions (“Activation”) to iQmetrix,...

Fourth quarter revenue growth of 10% year-over-year despite COVID headwindsFull-year 2021 revenue up 13% driven by strong growth in Joint Preservation and Restoration BEDFORD, Mass., March 08, 2022 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its fourth quarter and full year ended December 31, 2021. Fourth Quarter 2021 Financial SummaryRevenue in the fourth quarter of 2021 was $35.8 million, 10% higher than prior year, compared with $32.7 million in the fourth quarter of 2020, due primarily to favorable order timing in OA Pain Management despite COVID headwindsOA Pain Management1 revenue of $19.7 million, up 17% Joint Preservation and Restoration revenue of $13.3 million, up 1% Non-Orthopedic1 revenue of...

SAN FRANCISCO, March 08, 2022 (GLOBE NEWSWIRE) — Stitch Fix, Inc. (NASDAQ:SFIX), the leading online personal shopping and styling service, has released its financial results for the second quarter of fiscal year 2022 ended January 29, 2022. “In Q2, we delivered $517 million in net revenue, reflecting 3% year-over-year growth. Our revenue per active client topped $500 for the third quarter in a row, reaching a record $549, an increase of 18% from the same time last year as a result of higher average order values in our Fix business and the incrementality Freestyle provides to our existing clients,” said Elizabeth Spaulding, CEO of Stitch Fix. “While Freestyle revenue grew 29% year on year in the second quarter, we continue to experience challenges with onboarding and conversion of clients, which are not where we want them to be....

Fourth quarter revenue grew 24% year-over-year to $67.0 million Full year fiscal 2022 revenue grew 19% year-over-year to $242.1 million REDWOOD CITY, Calif , March 08, 2022 (GLOBE NEWSWIRE) — Sumo Logic (NASDAQ: SUMO), the SaaS analytics platform to enable reliable and secure cloud-native applications, today announced financial results for the fourth quarter and fiscal year 2022, ended January 31, 2022. “We delivered 24% growth in the fourth quarter and were able to execute on our plan to reaccelerate revenue growth in the back half of fiscal 2022. Across the markets we serve, digital transformation and cloud migration initiatives remain high priority, and were key drivers of the strength and contribution we saw across our customer base this quarter,” said Ramin Sayar, president and CEO of Sumo Logic. “Our highly differentiated...

SANTA CLARA, Calif., March 08, 2022 (GLOBE NEWSWIRE) —  Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a woman’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), today reported fourth quarter and full-year financial results for the period ended December 31, 2021. Fourth Quarter and Business Highlights:Reported revenue of $13.65 million in the fourth quarter of 2021, compared with revenue of $13.55 million in the fourth quarter of 2020, a nominal increase over the prior period.   Expanded contract coverage in 2021 to broaden commercial opportunity in approximately 500 hospitals.   Drove first time orders with 285 new hospital customers in 2021. Refinanced existing long-term debt facility with a new $40 million, five-year term loan from CIBC, substantially reducing the...